Method for the treatment of atherosclerosis, thrombosis and peripheral vessel disease
CA 1320904 C · Owner: Hoechst Aktiengesellschaft · Inventors: Scholkens, Bernward
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Abstract of the Disclosure: The invention relates to a method for the treatment of atherosclerosis, thrombosis and/or of peripheral vessel disease by administration of angiotensin converting enzyme inhibitors. Administration of compounds of the formula I, (I), in which n is 1 or 2, R R1, R2 and R3 are identical, or different and each denotes hydrogen or an organic radical, and R4 and R5 form, together with the atoms carrying them, a mono-, bi- or tricyclic heterocyclic ring system, is preferred. The invention also relates to angiotensin converting enzyme inhibitors and to agents containing them for administration for the treatment of the abovementioned diseases.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted August 3, 1993. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended August 3, 2010.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.